238 related articles for article (PubMed ID: 2316222)
1. [Hemolyzing antibodies to markers of the P blood factor system as a problem in blood transfusion and pregnancy. With reference to serology, biochemistry and genetics].
Pausch V; Speiser P; Michl U; Höcker P; Engelfriet CP
Wien Klin Wochenschr; 1990 Feb; 102(3):80-90. PubMed ID: 2316222
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin subclass (IgG3) restriction of anti-P and anti-Pk antibodies in patients of the rare p blood group.
Söderström T; Enskog A; Samuelsson BE; Cedergren B
J Immunol; 1985 Jan; 134(1):1-3. PubMed ID: 3964810
[TBL] [Abstract][Full Text] [Related]
3. [Pregnancy with an extremely rare P blood group with anti-PP1Pk].
Strowitzki T; Wiedemann R; Heim MU; Brehm G; Roithmeier A
Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):710-3. PubMed ID: 1743470
[TBL] [Abstract][Full Text] [Related]
4. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records].
Schönitzer D
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796
[TBL] [Abstract][Full Text] [Related]
5. A case of fatal hemolytic disease of the newborn associated with-D-/-D-phenotype.
Han KS; Kim HC; Han KS; Shim WS
Am J Perinatol; 1997 Sep; 14(8):495-7. PubMed ID: 9376014
[TBL] [Abstract][Full Text] [Related]
6. [A rare blood group: p phenotype].
De La Vega Elena CD; Hellberg A; Bonetti S; Gonzalez CA; Chialina S; Raillon MA; Pivetta MA; Solis EA; Olsson ML
Medicina (B Aires); 2009; 69(6):651-4. PubMed ID: 20053607
[TBL] [Abstract][Full Text] [Related]
7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
8. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
[TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis for the treatment of repeated early pregnancy wastage associated with anti-P.
Rock JA; Shirey RS; Braine HG; Ness PM; Kickler TS; Niebyl JR
Obstet Gynecol; 1985 Sep; 66(3 Suppl):57S-60S. PubMed ID: 4022518
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical observations on the human blood group P system.
Watkins WM; Morgan WT
J Immunogenet; 1976 Feb; 3(1):15-27. PubMed ID: 932463
[TBL] [Abstract][Full Text] [Related]
11. The first example of anti-Dia antibody in Poland.
Kuśnierz-Alejska G; Bochenek S; Zukowska B
Mater Med Pol; 1990; 22(1):15-6. PubMed ID: 2079854
[TBL] [Abstract][Full Text] [Related]
12. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
[TBL] [Abstract][Full Text] [Related]
13. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
Trevett TN; Moise KJ
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
[TBL] [Abstract][Full Text] [Related]
14. Treatment with plasma exchange of a pregnant woman with anti-PP1Pk alloimmunization: A case report.
Pignalosa O; Vigorita E; Capuano M; Caruso S; Mastroianni A; De Martino S; Vaccaro G; Meomartini D; Nocera C
Transfus Apher Sci; 2024 Apr; 63(2):103871. PubMed ID: 38245405
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the test using polybrene for the detection of anti-erythrocyte antibodies].
Lenkiewicz B
Acta Haematol Pol; 1991; 22(1):127-35. PubMed ID: 1823954
[TBL] [Abstract][Full Text] [Related]
16. [Hemolytic disease in a newborn infant caused by rare maternal anti-erythrocyte antibodies and exchange transfusion with maternal blood frozen earlier].
Castel A; Drejer GF; Verwey RA
Ned Tijdschr Geneeskd; 1993 Dec; 137(52):2713-5. PubMed ID: 8289944
[TBL] [Abstract][Full Text] [Related]
17. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies.
Moulds MK
Am J Med Technol; 1981 Oct; 47(10):789-95. PubMed ID: 7199253
[TBL] [Abstract][Full Text] [Related]
18. [Thrombocytic alloantigens and methods for their determination (significance of blood group serology)].
Winter PM
Wien Med Wochenschr; 1986 Feb; 136(3):57-63. PubMed ID: 2421491
[TBL] [Abstract][Full Text] [Related]
19. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
